Moreover, the transcription factors FOXC2 and NFATc1 are both involved in lymphatic valve development and the maturation of the lymphatic system, which may provide potential therapeutic means for the treatment of lymphedema (Norrmén et al., 2009). This evidence concerns the gene FOXC2 and lymphedema.